Literature DB >> 19587008

Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.

Nathaniel M Green1, Amy Laws, Kerstin Kiefer, Liliana Busconi, You-Me Kim, Melanie M Brinkmann, Erin Hodges Trail, Kei Yasuda, Sean R Christensen, Mark J Shlomchik, Stefanie Vogel, John H Connor, Hidde Ploegh, Dan Eilat, Ian R Rifkin, Jean Maguire van Seventer, Ann Marshak-Rothstein.   

Abstract

Type I IFNs play an important, yet poorly characterized, role in systemic lupus erythematosus. To better understand the interplay between type I IFNs and the activation of autoreactive B cells, we evaluated the effect of type I IFN receptor (IFNAR) deficiency in murine B cell responses to common TLR ligands. In comparison to wild-type B cells, TLR7-stimulated IFNAR(-/-) B cells proliferated significantly less well and did not up-regulate costimulatory molecules. By contrast, IFNAR1(-/-) B cells did not produce cytokines, but did proliferate and up-regulate activation markers in response to other TLR ligands. These defects were not due to a difference in the distribution of B cell populations or a failure to produce a soluble factor other than a type I IFN. Instead, the compromised response pattern reflected the disruption of an IFN-beta feedback loop and constitutively low expression of TLR7 in the IFNAR1(-/-) B cells. These results highlight subtle differences in the IFN dependence of TLR7 responses compared with other TLR-mediated B cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587008      PMCID: PMC2929820          DOI: 10.4049/jimmunol.0803899

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

Authors:  P C Familletti; R McCandliss; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

2.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.

Authors:  Petar Lenert; Rachel Brummel; Elizabeth H Field; Robert F Ashman
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

4.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.

Authors:  J A Symons; A Alcamí; G L Smith
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

5.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

6.  Type I IFN protects against murine lupus.

Authors:  Jonathan D Hron; Stanford L Peng
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

8.  Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice.

Authors:  H Wang; M J Shlomchik
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

9.  Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.

Authors:  Melissa W Boulé; Courtney Broughton; Fabienne Mackay; Shizuo Akira; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Exp Med       Date:  2004-06-14       Impact factor: 14.307

10.  Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.

Authors:  L Fiette; C Aubert; U Müller; S Huang; M Aguet; M Brahic; J F Bureau
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.

Authors:  Suwan Sinha; Yuhong Guo; Suwannee Thet; Dorothy Yuan
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

4.  Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.

Authors:  Ming You; Guanjun Dong; Fanlin Li; Feiya Ma; Jing Ren; Yujun Xu; Huimin Yue; Ruijing Tang; Deshan Ren; Yayi Hou
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

5.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

Review 6.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Authors:  Mélanie Souyris; José E Mejía; Julie Chaumeil; Jean-Charles Guéry
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 7.  Regulation of autoreactive B cell responses to endogenous TLR ligands.

Authors:  Ana Maria Avalos; Liliana Busconi; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  Cutting Edge: Direct Sensing of TLR7 Ligands and Type I IFN by the Common Myeloid Progenitor Promotes mTOR/PI3K-Dependent Emergency Myelopoiesis.

Authors:  Matthew B Buechler; Holly M Akilesh; Jessica A Hamerman
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

9.  Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.

Authors:  Jennie A Hamilton; Qi Wu; PingAr Yang; Bao Luo; Shanrun Liu; Huixian Hong; Jun Li; Mark R Walter; Eleanor N Fish; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2017-09-13       Impact factor: 5.422

10.  B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.

Authors:  Melissa M Walker; Bergren W Crute; John C Cambier; Andrew Getahun
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.